Literature DB >> 3881478

Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.

W A Vel, F Namavar, A M Verweij-van Vught, A N Pubben, D M MacLaren.   

Abstract

The inhibitory effect of Bacteroides fragilis on the in vitro killing of Escherichia coli by polymorphonuclear leucocytes was studied with two pairs of E coli and B fragilis isolated from human wound infections. Both B fragilis strains behaved similarly: they inhibited the killing of one E coli strain, while the killing of the other E coli strain was not affected. The different behaviour of the two E coli strains depended on their need for fresh serum in the killing by the polymorphonuclear leucocytes. The inhibitory effect of the B fragilis strains could be completely accounted for by their effect on complement.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3881478      PMCID： PMC499078          DOI： 10.1136/jcp.38.1.86

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  14 in total

1.  Comparison of the biochemical properties of Bacteroides melaninogenicus from human dental plaque and other sites.

Authors:  H N Shah; R A Williams; G H Bowden; J M Hardie
Journal:  J Appl Bacteriol       Date:  1976-12

2.  Bacterial synergy in mixed aerobic/anaerobic infections.

Authors:  F Namavar; A M van Vught; D M MacLaren
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

3.  Effect of Bacteroides fragilis on the peritoneal clearance of Escherichia coli in mice.

Authors:  M Reznikov; J J Finlay-Jones; P J McDonald
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

4.  Inhibition of phagocytosis in vitro by obligate anaerobes.

Authors:  H R Ingham; P R Sisson; D Tharagonnet; J B Selkon; A A Codd
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

5.  Impairment by Bacteroides species of opsonisation and phagocytosis of enterobacteria.

Authors:  G R Jones; C G Gemmell
Journal:  J Med Microbiol       Date:  1982-08       Impact factor: 2.472

6.  Surface antigens as virulence factors in infection with Bacteroides fragilis.

Authors:  D L Kasper; A B Onderdonk; B F Polk; J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

7.  Encapsulation of Bacteroides species.

Authors:  J L Babb; C S Cummins
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.

Authors:  G L Simon; M S Klempner; D L Kasper; S L Gorbach
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

9.  The quantitative and histological demonstration of pathogenic synergy between Escherichia coli and Bacteroides fragilis in guinea-pig wounds.

Authors:  M J Kelly
Journal:  J Med Microbiol       Date:  1978-11       Impact factor: 2.472

10.  Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.

Authors:  R W Tofte; P K Peterson; D Schmeling; J Bracke; Y Kim; P G Quie
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441
View more
  3 in total

1.  Effect of Bacteroides fragilis on the phagocytic killing of Escherichia coli.

Authors:  J J Finlay-Jones; M Reznikov
Journal:  J Clin Pathol       Date:  1985-08       Impact factor: 3.411

2.  Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

Authors:  F Namavar; J A Kaan; A M Verweij-van Vught; W A Vel; M Bal; A D Kester; D M MacLaren
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

3.  Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.

Authors:  W A Vel; F Namavar; A M Verweij-van Vught; A N Pubben; D M MacLaren
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.